-
RAPP Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Rapport Therapeutics, Inc. Common Stock (RAPP)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 39.42 mm | 39.42 mm | 39.42 mm | |||
Cash burn (monthly) | 23.62 mm | 7.21 mm | (no burn) | |||
Cash used (since last report) | 107.57 mm | 32.86 mm | n/a | |||
Cash remaining | -68.15 mm | 6.56 mm | n/a | |||
Runway (months of cash) | -2.9 | 0.9 | n/a |
13F holders | Current |
---|---|
Total holders | 56 |
Opened positions | 50 |
Closed positions | 0 |
Increased positions | 2 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 523.45 bn |
Total shares | 33.97 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
FMR | 5.49 mm | $112.36 bn |
Arch Venture | 3.73 mm | $76.36 bn |
ARCH Venture Fund XII | 3.73 mm | $100.08 mm |
Cormorant Asset Management | 2.94 mm | $60.23 bn |
Capital International Investors | 2.60 mm | $53.30 bn |
JNJ Johnson & Johnson | 2.50 mm | $51.16 bn |
Sofinnova Investments | 2.00 mm | $40.87 bn |
Sofinnova Venture Partners XI | 1.86 mm | $48.80 mm |
T. Rowe Price Investment Management | 1.73 mm | $35.37 mm |
GS The Goldman Sachs Group, Inc. | 1.25 mm | $25.54 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | Troy A. Ignelzi | Stock Option Common Stock | Grant | Acquire A | No | No | 16.6 | 142,000 | 2.36 mm | 142,000 |
3 Feb 25 | Krishnaswamy Yeleswaram | Stock Option Common Stock | Grant | Acquire A | No | No | 16.6 | 110,000 | 1.83 mm | 110,000 |
3 Feb 25 | David Bredt | Stock Option Common Stock | Grant | Acquire A | No | No | 16.6 | 100,000 | 1.66 mm | 100,000 |
3 Feb 25 | Abraham Ceesay | Stock Option Common Stock | Grant | Acquire A | No | No | 16.6 | 428,000 | 7.10 mm | 428,000 |
3 Feb 25 | Cheryl Gault | Stock Option Common Stock | Grant | Acquire A | No | No | 16.6 | 129,000 | 2.14 mm | 129,000 |